Compounds > lamivudine
Page last updated: 2024-08-24

lamivudine and Multiple Myeloma

lamivudine has been researched along with Multiple Myeloma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goh, YT; Han, ST; Hwang, WY; Linn, YC; Mya, DH; Tan, DC1
Boninsegna, S; Caroli, D; Fagiuoli, S; Floreani, A; Lobello, S1
Motta, M; Pelizzari, A; Puoti, M; Rossi, G1

Other Studies

3 other study(ies) available for lamivudine and Multiple Myeloma

ArticleYear
Risk of hepatitis B reactivation and the role of novel agents and stem-cell transplantation in multiple myeloma patients with hepatitis B virus (HBV) infection.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antiviral Agents; Boronic Acids; Bortezomib; Comorbidity; Endemic Diseases; Female; Hepatitis B; Humans; Immunologic Factors; Incidence; Lamivudine; Male; Middle Aged; Multiple Myeloma; Prevalence; Prospective Studies; Pyrazines; Retrospective Studies; Risk Factors; Secondary Prevention; Stem Cell Transplantation; Transplantation, Autologous; Virus Activation

2012
Fatal hepatic decompensation in a bone marrow transplant recipient with HBV-related cirrhosis following lamivudine withdrawal.
    Gastroenterologie clinique et biologique, 2006, Volume: 30, Issue:2

    Topics: Bone Marrow Transplantation; Fatal Outcome; Hepatitis B; Hepatitis B virus; Humans; Immunocompromised Host; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Multiple Myeloma; Renal Insufficiency; Reverse Transcriptase Inhibitors; Sepsis; Virus Activation

2006
Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy.
    British journal of haematology, 2001, Volume: 115, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hodgkin Disease; Humans; Lamivudine; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Pilot Projects; Prednisone; Vidarabine; Vincristine; Virus Activation

2001